[Journal logo]

Volume 65 
Part 4 
Page m459  
April 2009  

Received 6 March 2009
Accepted 23 March 2009
Online 28 March 2009

Key indicators
Single-crystal X-ray study
T = 173 K
Mean [sigma](C-C) = 0.004 Å
R = 0.037
wR = 0.081
Data-to-parameter ratio = 12.3
Details
Open access

Tetraaquabis[(1-ammonio-1-phosphonoethyl)phosphonato]zinc(II) tetrahydrate

aInstitute of General and Inorganic Chemistry, NAS Ukraine, Kyiv, prosp. Palladina 32/34, 03680 Ukraine
Correspondence e-mail: dudco_anatolij@ukr.net

The title compound, [Zn(C2H8NO6P2)2(H2O)4]·4H2O, was synthesized by the reaction of ZnCl2 with 1-aminoethane-1,1-diyldiphosphonic acid in aqueous solution. The asymmetric unit contains one-half of the complex and two water molecules of solvation. The Zn atom occupies a special position on an inversion centre. This results in a slightly distorted octahedral coordination environment, which consists of the O atoms from two phosphonic acids and four water molecules. The crystal structure displays N-H...O and O-H...O hydrogen bonding, which creates a three-dimensional network.

Related literature

Diphosphonic acids are efficient drugs for the prevention of calcification and the inhibition of bone resorption, see: Matczak-Jon & Videnova-Adrabinska (2005[Matczak-Jon, E. & Videnova-Adrabinska, V. (2005). Coord. Chem. Rev. 249, 2458-2488.]). Diphosphonic acids and their metal complexes are used in the treatment of Pagets disease, osteoporosis and tumoral osteolysis, see: Szabo et al. (2002[Szabo, Ch. M., Martin, M. B. & Oldfield, E. (2002). J. Med. Chem. 45, 2894-2903.]). For related structures, see: Li et al. (2006[Li, M., Chen, S., Xiang, J., He, H., Yuan, L. & Sun, J. (2006). Cryst. Growth Des. 6, 1250-1255.], 2007[Li, M. & Sun, J.-T. (2007). Acta Cryst. E63, m1370-m1372.]); Lin et al. (2007[Lin, L., Zhang, T., Fan, Y., Ding, D. & Hou, H. (2007). J. Mol. Struct. 837, 107-117.]).

[Scheme 1]

Experimental

Crystal data
  • [Zn(C2H8NO6P2)2(H2O)4]·4H2O

  • Mr = 617.57

  • Triclinic, [P \overline 1]

  • a = 5.6712 (4) Å

  • b = 9.3279 (6) Å

  • c = 10.7009 (7) Å

  • [alpha] = 96.440 (3)°

  • [beta] = 90.788 (3)°

  • [gamma] = 102.080 (3)°

  • V = 549.65 (6) Å3

  • Z = 1

  • Mo K[alpha] radiation

  • [mu] = 1.50 mm-1

  • T = 173 K

  • 0.36 × 0.10 × 0.04 mm

Data collection
  • Bruker APEXII CCD diffractometer

  • Absorption correction: numerical (SADABS; Bruker, 2005[Bruker (2005). APEX2, SAINT and SADABS. Bruker AXS Inc., Madison, Wisconsin, USA.]) Tmin = 0.612, Tmax = 0.945

  • 8897 measured reflections

  • 2244 independent reflections

  • 1747 reflections with I > 2[sigma](I)

  • Rint = 0.058

Refinement
  • R[F2 > 2[sigma](F2)] = 0.037

  • wR(F2) = 0.081

  • S = 1.00

  • 2244 reflections

  • 182 parameters

  • 1 restraint

  • H atoms treated by a mixture of independent and constrained refinement

  • [Delta][rho]max = 0.39 e Å-3

  • [Delta][rho]min = -0.48 e Å-3

Table 1
Hydrogen-bond geometry (Å, °)

D-H...A D-H H...A D...A D-H...A
N1-H1A...O6i 0.93 (4) 1.96 (4) 2.796 (4) 150 (3)
N1-H1B...O10 0.85 (4) 1.99 (4) 2.827 (4) 168 (3)
N1-H1C...O3i 0.90 (4) 2.01 (4) 2.851 (3) 153 (3)
O2-H2O...O3ii 0.78 (3) 1.76 (3) 2.536 (3) 172 (4)
O5-H5O...O6iii 0.793 (18) 1.726 (19) 2.519 (3) 177 (4)
O7-H71...O8iv 0.84 (4) 2.05 (4) 2.826 (3) 155 (3)
O7-H72...O10 0.76 (4) 2.00 (4) 2.748 (3) 168 (4)
O8-H81...O2 0.82 (4) 1.97 (4) 2.772 (3) 163 (3)
O8-H82...O9 0.86 (4) 1.79 (4) 2.646 (3) 174 (3)
O9-H91...O5v 0.87 (4) 1.94 (4) 2.810 (3) 172 (3)
O9-H92...O4vi 0.83 (4) 1.91 (4) 2.715 (3) 165 (4)
O10-H101...O4vii 0.85 (4) 1.90 (4) 2.744 (3) 175 (3)
O10-H102...O9iv 0.80 (4) 1.96 (4) 2.741 (3) 167 (4)
Symmetry codes: (i) x+1, y, z; (ii) -x, -y+2, -z+1; (iii) -x, -y+2, -z; (iv) -x+1, -y+1, -z+1; (v) x, y, z+1; (vi) -x, -y+1, -z+1; (vii) -x, -y+1, -z.

Data collection: APEX2 (Bruker, 2005[Bruker (2005). APEX2, SAINT and SADABS. Bruker AXS Inc., Madison, Wisconsin, USA.]); cell refinement: SAINT (Bruker, 2005[Bruker (2005). APEX2, SAINT and SADABS. Bruker AXS Inc., Madison, Wisconsin, USA.]); data reduction: SAINT; program(s) used to solve structure: SHELXS97 (Sheldrick, 2008[Sheldrick, G. M. (2008). Acta Cryst. A64, 112-122.]); program(s) used to refine structure: SHELXL97 (Sheldrick, 2008[Sheldrick, G. M. (2008). Acta Cryst. A64, 112-122.]); molecular graphics: SHELXTL (Sheldrick, 2008[Sheldrick, G. M. (2008). Acta Cryst. A64, 112-122.]); software used to prepare material for publication: publCIF (Westrip, 2009[Westrip, S. P. (2009). publCIF. In preparation.]).


Supplementary data and figures for this paper are available from the IUCr electronic archives (Reference: FJ2201 ).


References

Bruker (2005). APEX2, SAINT and SADABS. Bruker AXS Inc., Madison, Wisconsin, USA.
Li, M., Chen, S., Xiang, J., He, H., Yuan, L. & Sun, J. (2006). Cryst. Growth Des. 6, 1250-1255.  [CSD] [CrossRef] [ChemPort]
Li, M. & Sun, J.-T. (2007). Acta Cryst. E63, m1370-m1372.  [CSD] [CrossRef] [details]
Lin, L., Zhang, T., Fan, Y., Ding, D. & Hou, H. (2007). J. Mol. Struct. 837, 107-117.  [ISI] [CSD] [CrossRef] [ChemPort]
Matczak-Jon, E. & Videnova-Adrabinska, V. (2005). Coord. Chem. Rev. 249, 2458-2488.  [ISI] [CrossRef] [ChemPort]
Sheldrick, G. M. (2008). Acta Cryst. A64, 112-122.  [CrossRef] [details]
Szabo, Ch. M., Martin, M. B. & Oldfield, E. (2002). J. Med. Chem. 45, 2894-2903.  [ISI] [CrossRef] [PubMed] [ChemPort]
Westrip, S. P. (2009). publCIF. In preparation.


Acta Cryst (2009). E65, m459  [ doi:10.1107/S1600536809010599 ]

This is an open-access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original authors and source are cited.